Cyclosporine immunomodulation in a rabbit model of chronic hypersensitivity pneumonitis.
Rabbit models of chronic experimental hypersensitivity pneumonitis and desensitization were used to evaluate the effects of systemic cyclosporine. When administered 12 to 18 h before each inhalational challenge with aerosolized antigen and the adjuvant muramyl dipeptide, cyclosporine suppressed the development of disease as well as the anamnestic antibody response, particularly in bronchoalveolar lavage fluids. When administered at the time of sensitization only, cyclosporine suppressed the primary antibody response but not the anamnestic antibody response or the disease. Antigen- and mitogen-induced blastogenesis was inhibited by cyclosporine in vitro, but antigen-specific blastogenesis was not abrogated by cyclosporine previously administered in vivo. These results indicate that cyclosporine caused profound immunomodulation in this model, which can be at least partially explained by transient suppressive effects on T cells, particularly the helper/inducer and delayed hypersensitivity subset(s).
D000542:Alveolitis, Extrinsic Allergic / Q000276:immunology*; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D002908:Chronic Disease; D003524:Cyclosporins / Q000494:pharmacology*; D004195:Disease Models, Animal; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000517:prevention & control; D005260:Female; D006968:Hypersensitivity, Delayed; D007074:Immunoglobulin G / Q000032:analysis; D008214:Lymphocytes / Q000187:drug effects; D008222:Lymphokines / Q000096:biosynthesis; D010047:Ovalbumin / Q000276:immunology; D011817:Rabbits; D007507:Therapeutic Irrigation
D003524:Cyclosporins; D007074:Immunoglobulin G; D008222:Lymphokines; D010047:Ovalbumin